Latest Breaking News On - Precision genetic medicine engine - Page 2 : comparemela.com

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomIan estepanSarepta therapeutics incCompensation committeeCommencement incentive planNasdaq listing ruleGrant datePrecision genetic medicine engineFor investor

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDoug ingramIan estepanExchange agreementsBiomarin pharmaceuticals incRoche ltdTrademark officeExchange commissionDrug administrationUniversity of western australiaSarepta therapeutics incThermo fisher scientific incRecent developmentsBiologics license applicationPriority review

Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program

Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesDiane berryScholarship programSarepta therapeutics incDuchenne scholarship programSarepta therapeuticsExecutive vice presidentChief global policyDuchenne scholarshipPrecision genetic medicine engine

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on Feb. 29, 2024 that were previously approved by the Compensation Committee of its.

Compensation committeeSarepta therapeutics incSarepta therapeuticsCommencement incentive planNasdaq listing ruleGrant datePrecision genetic medicine engineFor investor

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

United kingdomIan estepanCompensation committeeSarepta therapeutics incCommencement incentive planNasdaq listing ruleGrant datePrecision genetic medicine engineFor investorSarepta therapeutics